22nd Century Group Initiates Process To Evaluate Strategic Alternatives For Its Tobacco Portfolio
(RTTNews) - Agricultural biotechnology company 22nd Century Group, Inc. (XXII) announced Tuesday that its Board of Directors, after consultation with its financial and legal advisors, has initiated a process to evaluate strategic alternatives with respect to the Company's tobacco assets.
The process will include consideration of a range of strategic, operational and financial transactions and alternatives, such as business combinations, asset sales, licensing agreements, alternate financing strategies and other options.
The company said it hopes to identify ways to monetize the value or more effectively expand the market reach of its tobacco portfolio, including its innovative VLN tobacco harm reduction products, the first and only combustible tobacco product to receive a Modified Risk Tobacco Product designation from the U.S. Food and Drug Administration.
The Company has engaged TD Cowen as advisors in its review of strategic alternatives.
22nd Century Group Names Hugh Kinsman As CFO
Australia Rate Decision On Tap For Tuesday
Canadian Stocks Turning In Mixed Performance; TSX Down Marginally
Swiss Market Pares Early Gains, Settles Flat
European Stocks Close Higher As Investors Asses Economic Data, Recent Earnings
U.S. Manufacturing Index Unexpectedly Edges Lower In October
Bay Street Likely To Open On Positive Note
